These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30269670)

  • 1. Interleukin-18 is associated with the presence of interstitial lung disease in rheumatoid arthritis: a cross-sectional study.
    Matsuo T; Hashimoto M; Ito I; Kubo T; Uozumi R; Furu M; Ito H; Fujii T; Tanaka M; Terao C; Kono H; Mori M; Hamaguchi M; Yamamoto W; Ohmura K; Morita S; Mimori T
    Scand J Rheumatol; 2019 Mar; 48(2):87-94. PubMed ID: 30269670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum soluble programmed death ligand 1(sPD-L1) is associated with the presence of interstitial lung disease in rheumatoid arthritis: A monocentric cross-sectional study.
    Wu X; Xu L; Cheng Q; Nie L; Zhang S; Du Y; Xue J
    Respir Med; 2020 May; 166():105948. PubMed ID: 32250876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble programmed death molecule 1 (sPD-1) as a predictor of interstitial lung disease in rheumatoid arthritis.
    Xu L; Jiang L; Nie L; Zhang S; Liu L; Du Y; Xue J
    BMC Immunol; 2021 Oct; 22(1):69. PubMed ID: 34654367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.
    Doyle TJ; Patel AS; Hatabu H; Nishino M; Wu G; Osorio JC; Golzarri MF; Traslosheros A; Chu SG; Frits ML; Iannaccone CK; Koontz D; Fuhrman C; Weinblatt ME; El-Chemaly SY; Washko GR; Hunninghake GM; Choi AM; Dellaripa PF; Oddis CV; Shadick NA; Ascherman DP; Rosas IO
    Am J Respir Crit Care Med; 2015 Jun; 191(12):1403-12. PubMed ID: 25822095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of serum interleukin-13 and interleukin-13 receptor subunit expressions: Rheumatoid arthritis-associated interstitial lung disease.
    Hussein MS; El-Barbary AM; Nada DW; Gaber RA; Elkolaly RM; Aboelhawa MA
    Int J Rheum Dis; 2021 Apr; 24(4):591-598. PubMed ID: 33638296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease.
    Avouac J; Cauvet A; Steelandt A; Shirai Y; Elhai M; Kuwana M; Distler O; Allanore Y
    PLoS One; 2020; 15(5):e0232978. PubMed ID: 32384128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum alarmins and the risk of incident interstitial lung disease in rheumatoid arthritis.
    Poole JA; England BR; Sayles H; Johnson TM; Duryee MJ; Hunter CD; Baker JF; Kerr GS; Kunkel G; Cannon GW; Sauer BC; Wysham KD; Joseph AM; Wallace BI; Thiele GM; Mikuls TR
    Rheumatology (Oxford); 2024 Jul; 63(7):1998-2005. PubMed ID: 37812235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The serum level and significance of lysyl oxidase-like 2 in patients with rheumatoid arthritis-associated interstitial lung disease.
    Fu Q; Bai Y; Liu Y; Zhou J; Zheng Y
    Clin Rheumatol; 2018 Jan; 37(1):193-198. PubMed ID: 29052023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidimensional biomarker approach integrating tumor markers, inflammatory indicators, and disease activity indicators may improve prediction of rheumatoid arthritis-associated interstitial lung disease.
    Wan J; Yu Z; Cao X; Zhao X; Zhou W; Zheng Y
    Clin Rheumatol; 2024 Jun; 43(6):1855-1863. PubMed ID: 38704780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-4 in rheumatoid arthritis patients with interstitial lung disease: a pilot study.
    Shen H; Xia L; Lu J
    Indian J Med Res; 2013 Dec; 138(6):919-21. PubMed ID: 24521636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum YKL-40 and Serum Krebs von den Lungen-6 as Potential Predictive Biomarkers for Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Liang B; Zhang Y; Ke D; Yan R; Jiang MN; Li L; Zhang LX; Zhao XG; Yuan GP; Xu B; Liu XM
    Immunol Invest; 2024 Aug; 53(6):989-1000. PubMed ID: 38900045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and diagnostic value of interleukin-22 in rheumatoid arthritis-associated interstitial lung disease.
    Fang Q; Xie J; Zong J; Zhou Y; Zhou Q; Yin S; Cao L; Yin H; Zhou D
    Int Immunopharmacol; 2024 Jun; 134():112173. PubMed ID: 38728884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma IL-36α and IL-36γ as Potential Biomarkers in Interstitial Lung Disease Associated with Rheumatoid Arthritis: a Pilot Study in the Chinese Population.
    Zheng W; Hu X; Zou M; Hu N; Song W; Wang R; Liu Y; Hou Q; Liu Y; Chen X; Cheng Z
    Inflammation; 2023 Feb; 46(1):285-296. PubMed ID: 36044099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet/Lymphocyte, Lymphocyte/Monocyte, and Neutrophil/Lymphocyte Ratios as Biomarkers in Patients with Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Chen Q; Chen DY; Xu XZ; Liu YY; Yin TT; Li D
    Med Sci Monit; 2019 Aug; 25():6474-6481. PubMed ID: 31462627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-cyclic citrullinated Peptide antibody is associated with interstitial lung disease in patients with rheumatoid arthritis.
    Yin Y; Liang D; Zhao L; Li Y; Liu W; Ren Y; Li Y; Zeng X; Zhang F; Tang F; Shan G; Zhang X
    PLoS One; 2014; 9(4):e92449. PubMed ID: 24743261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis.
    Yang JA; Lee JS; Park JK; Lee EB; Song YW; Lee EY
    Korean J Intern Med; 2019 Mar; 34(2):434-441. PubMed ID: 28352064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased incidence of autoantibodies to interleukin-1a in rheumatoid arthritis with interstitial lung disease.
    Maniwa K; Ogushi F; Tani K; Ohmoto Y; Muraguchi M; Sone S
    Respirology; 2000 Dec; 5(4):315-20. PubMed ID: 11192540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Profiling of Serum Protein Biomarkers in Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis.
    Kass DJ; Nouraie M; Glassberg MK; Ramreddy N; Fernandez K; Harlow L; Zhang Y; Chen J; Kerr GS; Reimold AM; England BR; Mikuls TR; Gibson KF; Dellaripa PF; Rosas IO; Oddis CV; Ascherman DP
    Arthritis Rheumatol; 2020 Mar; 72(3):409-419. PubMed ID: 31532072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory Biomarkers in the Diagnosis and Prognosis of Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Mena-Vázquez N; Godoy-Navarrete FJ; Lisbona-Montañez JM; Redondo-Rodriguez R; Manrique-Arija S; Rioja J; Mucientes A; Ruiz-Limón P; Garcia-Studer A; Ortiz-Márquez F; Oliver-Martos B; Cano-García L; Fernández-Nebro A
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Krebs von den Lungen-6 and lung ultrasound B lines as potential diagnostic and prognostic factors for rheumatoid arthritis-associated interstitial lung disease.
    Fotoh DS; Helal A; Rizk MS; Esaily HA
    Clin Rheumatol; 2021 Jul; 40(7):2689-2697. PubMed ID: 33474659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.